Gastric cancer registry for patients and certain family members
Part of Cancer, Digestive system clinical trials.
This study builds a registry (a secure database) to learn about people with gastric cancer, people at higher risk because of family history, and people with a specific inherited gene change. Being in the registry may help researchers understand causes and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older
- Have a stomach (gastric) tumor confirmed by biopsy/pathology OR have close family history OR a known CDH1 gene change
- If you don’t have gastric cancer yourself, you must have a first- or second-degree relative with gastric cancer
- You (or your study team) must know whether you have a germline CDH1 (E-cadherin) gene mutation
- Be able to read and complete the online consent and questionnaires in English, or Spanish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study keeps an organized record of people diagnosed with esophagus, gastroesophageal junction, or stomach cancer. It helps researchers learn from real-world outcomes, based on health information collected over time.
This trial collects health information and samples (a “cancer repository”) to help researchers study cancer and cancer risk. You may be able to join if you’ve had cancer before or if you’re at higher risk or have concerning findings.
This study looks at stomach (or stomach–esophagus junction) cancer tissue, treatment details, and patient-reported experiences to better predict how you may respond to standard chemotherapy. It may help personalize future treatment by identifying markers that connect your tumor environment and your expected outcomes.
This study collects health information from people at different stages of stomach cancer risk, including those with precancerous changes, healthy individuals, and those with early stomach cancer. The goal is to better understand and prevent stomach cancer.
This trial looks at tiny pieces of DNA found outside cells in stomach tissue to better understand how gastric (stomach) cancer starts and progresses. It may help future patients by improving how doctors study stomach cancer from biopsy and surgical samples.
This study looks at people who carry a specific “loss-of-function” CTNNA1 gene change—or who are closely related to someone who does. It’s designed to better understand this genetic risk in families and may help guide future care and monitoring.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.